Stock SUN SURGICAL INNOVATIONS GROUP PLC
Add to a list
To use this feature you must be a member
Log inSign up

Financials Surgical Innovations Group plc

Equities

SUN

GB0004016704

Medical Equipment, Supplies & Distribution

Market Closed - London S.E.
Other stock markets
 11:35:14 2024-07-12 am EDT 		5-day change 1st Jan Change
0.7 GBX +7.69% Intraday chart for Surgical Innovations Group plc +27.27% +16.67%
Jun. 19 Surgical Innovations Group plc Announces the Termination of Mr. Paul James Hardy as Director CI
Jun. 10 Surgical Innovations names Weir's Chris Martin as CFO AN

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Capitalization 1 16.3 15.39 21.92 14.93 5.597 6.53
Enterprise Value (EV) 1 17.11 13.38 21.06 14.89 6.047 6.663
P/E ratio - - - - - -
Yield - - - - - -
Capitalization / Revenue 1.52 x 2.43 x 2.4 x 1.32 x 0.47 x 0.52 x
EV / Revenue 1.59 x 2.11 x 2.31 x 1.31 x 0.5 x 0.54 x
EV / EBITDA 11.8 x -20.3 x 42.1 x 21.3 x 30.2 x 12.1 x
EV / FCF - - -32.7 x -25.1 x -21 x 10.8 x
FCF Yield - - -3.06% -3.98% -4.76% 9.26%
Price to Book 1.34 x 1.39 x 2.06 x 1.36 x 0.54 x 0.68 x
Nbr of stocks (in thousands) 795,316 932,816 932,816 932,816 932,816 932,816
Reference price 2 0.0205 0.0165 0.0235 0.0160 0.006000 0.007000
Announcement Date 3/31/20 3/25/21 3/23/22 3/29/23 4/18/24 -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales 1 10.73 6.329 9.126 11.34 12.01 12.45
EBITDA 1 1.446 -0.66 0.5 0.7 0.2 0.5485
EBIT 1 0.54 -1.6 -0.347 0.113 -0.323 -0.1515
Operating Margin 5.03% -25.28% -3.8% 1% -2.69% -1.22%
Earnings before Tax (EBT) - - - - - -
Net income - - - - - -
Net margin - - - - - -
EPS - - - - - -
Free Cash Flow 1 - - -0.645 -0.592 -0.288 0.6169
FCF margin - - -7.07% -5.22% -2.4% 4.96%
FCF Conversion (EBITDA) - - - - - 112.47%
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/31/20 3/25/21 3/23/22 3/29/23 4/18/24 -
1GBP in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt 1 0.81 - - - 0.45 0.13
Net Cash position 1 - 2.01 0.86 0.04 - -
Leverage (Debt/EBITDA) 0.5574 x - - - 2.25 x 0.2428 x
Free Cash Flow 1 - - -0.65 -0.59 -0.29 0.62
ROE (net income / shareholders' equity) - - - - - -
ROA (Net income/ Total Assets) - - - - - -
Assets - - - - - -
Book Value Per Share 2 0.0200 0.0100 0.0100 0.0100 0.0100 0.0100
Cash Flow per Share - - - - - -
Capex - - - - - -
Capex / Sales - - - - - -
Announcement Date 3/31/20 3/25/21 3/23/22 3/29/23 4/18/24 -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.007 GBP
Average target price
0.02 GBP
Spread / Average Target
+185.71%
Consensus

Chiffre d''affaires - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
SURGICAL INNOVATIONS GROUP PLC Stock Surgical Innovations Group plc
+16.67% 8.48M
ABBOTT LABORATORIES Stock Abbott Laboratories
-5.31% 181B
MEDTRONIC PLC Stock Medtronic plc
-5.38% 99.95B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-6.04% 66.21B
HOYA CORPORATION Stock Hoya Corporation
+16.45% 45.4B
DEXCOM, INC. Stock DexCom, Inc.
-8.08% 45.36B
CENCORA, INC. Stock Cencora, Inc.
+8.38% 43.84B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+12.06% 29.03B
TERUMO CORPORATION Stock Terumo Corporation
+17.98% 25.64B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
-8.28% 23.53B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. SUN Stock
  4. Financials Surgical Innovations Group plc